A report published as a preprint in medRxiv May 21st by Shapiro and others helps to evaluate this issue. The authors used data from publication, reports, and press releases and concluded that the average efficacy of the Pfizer, Moderna, Johnson & Johnson,...
A study published in The Lancet Respiratory Medicine May 27th 2021 by Tardif and others researched this issue in relation to colchicine. Evidence suggests excessive inflammation in COVID-19 patients plays a role in the development of...
An interesting article published by Revollo and others in The Lancet Infectious Diseases May 27th 2021 sought to research and answer this question. The banning of mass gathering indoor events to prevent SARS-CoV-2 spread has had important effects on local...
An interesting correspondence by Lekpa and others published in The Lancet Infectious Diseases May 28th 2021 suggests that this is indeed the case. They feel that the clinical case and context for the suspicion of COVID-19 needs to be brought into the...
They are effective against the B.1.1.7 mutation which remains the dominant strain across the United Kingdom and first detected in Kent This weekend Public Health England published a study which showed that cases of the B.1.617.2 strain had risen sharply in the...
An editorial published in the British Medical Journal May 17th by Dr David Smith and Dr Gill tries to answer this question. They feel that the target is over ambitious and may risk errors. The UK Government has launched a COVID-19 antiviral...
